Literature DB >> 2122148

Caffeine and human cerebral blood flow: a positron emission tomography study.

O G Cameron1, J G Modell, M Hariharan.   

Abstract

Positron emission tomography (PET) was used to quantify the effect of caffeine on whole brain and regional cerebral blood flow (CBF) in humans. A mean dose of 250 mg of caffeine produced approximately a 30% decrease in whole brain CBF; regional differences in caffeine effect were not observed. Pre-caffeine CBF strongly influenced the magnitude of the caffeine-induced decrease. Caffeine decreased paCO2 and increased systolic blood pressure significantly; the change in paCO2 did not account for the change in CBF. Smaller increases in diastolic blood pressure, heart rate, plasma epinephrine and norepinephrine, and subjectively reported anxiety were also observed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2122148     DOI: 10.1016/0024-3205(90)90174-p

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  54 in total

1.  Effects of a divided high loading dose of caffeine on circulatory variables in preterm infants.

Authors:  C Hoecker; M Nelle; B Beedgen; J Rengelshausen; O Linderkamp
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-01       Impact factor: 5.747

2.  Does acute caffeine ingestion alter brain metabolism in young adults?

Authors:  Feng Xu; Peiying Liu; James J Pekar; Hanzhang Lu
Journal:  Neuroimage       Date:  2015-01-30       Impact factor: 6.556

3.  Effects of anxiety sensitivity and expectations on the modulation of the startle eyeblink response during a caffeine challenge.

Authors:  Christoph Benke; Terry D Blumenthal; Christiane Modeß; Alfons O Hamm; Christiane A Pané-Farré
Journal:  Psychopharmacology (Berl)       Date:  2015-07-15       Impact factor: 4.530

4.  The Effects of Dietary Caffeine Use and Abstention on Blood Oxygen Level-Dependent Activation and Cerebral Blood Flow.

Authors:  Merideth A Addicott; Ann M Peiffer; Paul J Laurienti
Journal:  J Caffeine Res       Date:  2012-03

5.  A specific role for the thalamus in mediating the interaction of attention and arousal in humans.

Authors:  C M Portas; G Rees; A M Howseman; O Josephs; R Turner; C D Frith
Journal:  J Neurosci       Date:  1998-11-01       Impact factor: 6.167

6.  Quantitative mapping of cerebral metabolic rate of oxygen (CMRO2 ) using quantitative susceptibility mapping (QSM).

Authors:  Jingwei Zhang; Tian Liu; Ajay Gupta; Pascal Spincemaille; Thanh D Nguyen; Yi Wang
Journal:  Magn Reson Med       Date:  2014-09-26       Impact factor: 4.668

7.  Vascular effects of caffeine found in BOLD fMRI.

Authors:  Ho-Ching Shawn Yang; Zhenhu Liang; Jinxia Fiona Yao; Xin Shen; Blaise deB Frederick; Yunjie Tong
Journal:  J Neurosci Res       Date:  2018-11-29       Impact factor: 4.164

Review 8.  Pharmacological rationale for the clinical use of caffeine.

Authors:  J Sawynok
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

9.  Attenuation of cerebral venous contrast in susceptibility-weighted imaging of spontaneously breathing pediatric patients sedated with propofol.

Authors:  J Sedlacik; U Löbel; M Kocak; R B Loeffler; J R Reichenbach; A Broniscer; Z Patay; C M Hillenbrand
Journal:  AJNR Am J Neuroradiol       Date:  2010-01-06       Impact factor: 3.825

10.  Caffeine dose effect on activation-induced BOLD and CBF responses.

Authors:  Yufen Chen; Todd B Parrish
Journal:  Neuroimage       Date:  2009-03-13       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.